Results

Total Results: 1,636 records

Showing results for "treated".

1. Outcomes in COPD patients treated with theophylline (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/decide16final-mortality-risk-in-copd-pts-using-theophylline.pdf
   December 01, 2009 - Outcomes in COPD patients treated with theophylline The DEcIDE (Developing Evidence to … In the largest group, patients treated with ipratropium plus theophylline, compared to ipratropium alone … Patients treated with theophylline tended to fill more Effective Health Care Research Report Number

2. Outcomes in COPD patients treated with theophylline (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/copd-management_research.pdf
   December 01, 2009 - Outcomes in COPD patients treated with theophylline The DEcIDE (Developing Evidence to … In the largest group, patients treated with ipratropium plus theophylline, compared to ipratropium alone … Patients treated with theophylline tended to fill more Effective Health Care Research Report Number

3. Should subclinical hypothroidism be treated? | Effective Health Care (EHC) Program
   effectivehealthcare.ahrq.gov/get-involved/nominated-topics/should-subclinical-hypothroidism-be-treated

4. Cer-243-Prehospital-Airway-Management-Appendix-F-1 0 (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/cer-243-prehospital-airway-management-appendix-f-1_0.xlsx
   January 01, 2016 - SGA Pharyngeotracheal Luman Airway 25 ETI NR 15 O2/ventilation PO2 second 15 minutes after first As treated … SGA Pharyngeotracheal Luman Airway 25 ETI NR 14 O2/ventilation PaCO2 second 15 minutes after first As treated … SGA Pharyngeotracheal Luman Airway 25 ETI NR 14 O2/ventilation pH second 15 minutes after first As treated … As treated Technique/Device ETI: Metal vs. … As Treated NA NA SGA vs. ETI 3.9% (77/1968) vs. 4.7% (399/8487) AOR ETI vs.

5. Treating Infantile Hemangiomas in Children (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/infantile-hemangioma_consumer.pdf
   June 01, 2016 - � How are IHs treated? � What have researchers found about how well the treatments work? … What problems can an IH cause, and when should an IH be treated? … These problems are rare but may be permanent if the IH is not treated early. » For these more severe … Understanding Your Options How is an IH treated? … � Do you think my child’s IH could cause any problems if it is not treated?

6. Draft - Primary Hypofractionated Radiation Therapy for Localized Prostate Cancer: Appendix D2 Tables (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypofractionated-radiation-therapy-draft-appendix-d2.xlsx
   January 01, 2024 - For group 2, the prostate was treated to the prescribed dose, whereas the seminal vesicle was treated … For group 2, the prostate was treated to the prescribed dose, whereas the seminal vesicle was treated … All patients were treated with a >= 10-MV linear accelerator. … All patients were treated with a >= 10-MV linear accelerator. … For T3b patients, the entire SVs were treated with 68 Gy.

7. Cad-Pci-Bypass Surveillance (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_surveillance.pdf
   May 01, 2013 - Findings: - New RCT and cohort studies further delineate which patients have improved outcomes when treated … At 4 years of followup, patients treated with CABG had lower mortality than those treated with PCI … with PCI than patients treated with CABG (26.6% vs. 18.7%, p=0.005). … with PCI compared to patients treated with CABG (11.4% vs. 5.4%, p<0.001). … Stroke was less common among patients treated with PCI (0.1% vs. 1.7%, p=0.013).

8. Effectiveness and Safety of Bronchial Thermoplasty in Management of Asthma: Evidence Summary (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-202-bronchial-thermoplasty-asthma.pdf
   December 01, 2017 - studies, including three randomized controlled trials (RCTs) with 5-year single-arm followup in BT- treated … • Patients treated with BT and standard care used statistically significantly less rescue medication … • •Patients treated with BT and standard care had fewer emergency department (ED) visits compared … • Patients treated with BT developed the following common adverse events: bronchial irritation, chest … Serious adverse events occurred more frequently in BT-treated patients than in patients receiving sham

9. Layout 1 (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia_executive.pdf
   May 01, 2006 - occurs in 13-78 percent of patients undergoing treatment for solid tumors and 30-40 percent of patients treated … patients treated with epoetin or darbepoetin experienced a thromboembolic event, compared with 4 percent … However, trials varied widely in thromboembolic event rates: 0 percent to 30 percent among treated patients … All patients in the mild anemia arms were treated with an erythropoietic stimulant; of patients in whom … for mild anemia compared with those who were treated for moderate anemia.

10. Phenylketonuria Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/phenylketonuria_executive.pdf
    February 01, 2012 - Executive dysfunction in treated phenylketonuric patients. … Wechsler subscale IQ and subtest profile in early treated phenylketonuria. … MR imaging-based volumetry in patients with early-treated phenylketonuria. … Adult psychosocial outcome in early-treated phenylketonuria. … Neurological outcome in adult patients with early-treated phenylketonuria.

11. For patients with PKU, there is now a pharmaceutical drug to treat this condition. In the past is was treated by medical foods that eliminated the harmful substance phenylalanine. The cost of the new drug is $70K year. The cost to treat… | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/get-involved/nominated-topics/for-patients-with-pku-there-is-now-a-pharmaceutical-drug-to-treat-this-condition-in-the-past-is-was-treated-by-medical-foods-that-eliminated-the-harmful-substance-phenylalanine-the-cost-of-the-new-drug-is-70k-year-the-cost-t

12. Acs-Pci-Adjunctive-Devices Surveillance (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/acs-pci-adjunctive-devices_surveillance.pdf
    April 01, 2013 - One new meta-analysis reported better outcomes in patients treated with aspiration thrombectomy than … patients treated with PCI alone6 None 1 expert thought this was still valid 1 expert thought … than patients treated with PCI alone5 None Both experts thought this conclusion was still valid … with abciximab and not in patients treated with aspiration thrombectomy Vink, 20125 (PASSION) … with thrombus aspiration 619 Patients treated with thrombus aspiration did not have better outcomes

13. Treating and Preventing C. difficile Infections (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/c-difficile-update_consumer.pdf
    May 01, 2017 - � How is CDI treated? » What have researchers found about treatments for CDI? … Understanding Your Options How is CDI treated?

14. PULMONARY with "Discussions" in Exec Summary (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1412.pdf
    October 01, 2015 - In the phase III ASCEND trial, patients (n=555) with IPF treated with pirfenidone had a significant … first acute exacerbation compared with patients treated with placebo. … change from baseline in predicted FEV1 compared with patients treated with placebo (p<0.0001). … exacerbations than did patients treated with placebo (94 vs. 139; p=0.0116). … Patient survival at 6 months for patients with OCS-treated lungs (n=36) and cold storage treated lungs

15. Skin Substitutes for Treating Chronic Wounds (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/skin-substitute_0.pdf
    October 03, 2019 - be included if they address a guiding question; present data on patients with chronic wounds being treated

16. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_executive.pdf
    July 01, 2009 - Avoiding anticoagulation There is a low level of evidence suggesting that patients treated with RFA … have a better chance of avoiding anticoagulation than those treated with AADs. … It found a higher proportion of patients treated with RFA than patients treated with medical therapy … with RFA and those treated with AADs. … One RCT reported a lower readmission rate in patients treated with RFA than medical treatment (9 percent

17. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-update_executive.pdf
    June 01, 2011 - Although ACEIs and ARBs both target the renin system and are treated by clinicians as being equivalent … Others have estimated that angioedema is experienced by 1 in every 1,000 patients treated with an ACEI … , and 1 to 5 of every 10,000 of those treated with an ARB. … others have reported a three- to fourfold increased risk of angioedema in African-American patients treated … with an ACEI versus Caucasian patients treated with an ACEI.

18. Treatments for Fecal Incontinence: Current State of the Evidence (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/fecal-incontinence_clinician.pdf
    July 01, 2016 - sham injections 1 206 Severity The mean increase in number of FI-free days was greater in the treated … 3.5). ��� Severity There was no significant difference in improvement in the CCFIS score for the treated … of patients with a 50-percent or greater reduction in FI episodes at 6 months (52% of dextranomer-treated … patients vs. 31% of sham-treated patients). … of FI episodes over 2 weeks was not significantly different between groups at 3 months or 6 months (treated

19. Arthritis and Nontraumatic Joint Disease (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-13121.pdf
    December 05, 2013 - Patients treated with Mobi-C were reported to have a significantly higher success rate than patients … treated with ACDF at 6, 12, 18, and 24 months. … Additionally, patients treated with Mobi-C were reported to improve more than patients treated with … Patients treated with ACDF were reported to need reoperation more often than patients treated with … Overall, 3.6% of patients treated with Mobi-C and 6.7% of patients treated with ACDF had major complications

20. PULMONARY with "Discussions" in Exec Summary (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1506.pdf
    October 01, 2015 - In the phase III TRAFFIC and TRANSPORT trials, patients treated with lumacaftor/ivacaftor (Orkambi™ … time to the first acute exacerbation compared with patients treated with placebo. … change from baseline in ppFEV1 compared with patients treated with placebo (p<0.0001). … pulmonary exacerbations than did patients treated with placebo (94 vs. 139; p=0.0116). … Patient survival at 6 months for patients with OCS-treated lungs (n=36) and cold storage treated lungs